These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26316598)

  • 1. The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural Models.
    Ford D; Robins JM; Petersen ML; Gibb DM; Gilks CF; Mugyenyi P; Grosskurth H; Hakim J; Katabira E; Babiker AG; Walker AS;
    Am J Epidemiol; 2015 Oct; 182(7):633-43. PubMed ID: 26316598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
    ; Mugyenyi P; Walker AS; Hakim J; Munderi P; Gibb DM; Kityo C; Reid A; Grosskurth H; Darbyshire JH; Ssali F; Bray D; Katabira E; Babiker AG; Gilks CF; Grosskurth H; Munderi P; Kabuye G; Nsibambi D; Kasirye R; Zalwango E; Nakazibwe M; Kikaire B; Nassuna G; Massa R; Fadhiru K; Namyalo M; Zalwango A; Generous L; Khauka P; Rutikarayo N; Nakahima W; Mugisha A; Todd J; Levin J; Muyingo S; Ruberantwari A; Kaleebu P; Yirrell D; Ndembi N; Lyagoba F; Hughes P; Aber M; Lara AM; Foster S; Amurwon J; Wakholi BN; Whitworth J; Wangati K; Amuron B; Kajungu D; Nakiyingi J; Omony W; Fadhiru K; Nsibambi D; Khauka P; Mugyenyi P; Kityo C; Ssali F; Tumukunde D; Otim T; Kabanda J; Musana H; Akao J; Kyomugisha H; Byamukama A; Sabiiti J; Komugyena J; Wavamunno P; Mukiibi S; Drasiku A; Byaruhanga R; Labeja O; Katundu P; Tugume S; Awio P; Namazzi A; Bakeinyaga GT; Katabira H; Abaine D; Tukamushaba J; Anywar W; Ojiambo W; Angweng E; Murungi S; Haguma W; Atwiine S; Kigozi J; Namale L; Mukose A; Mulindwa G; Atwiine D; Muhwezi A; Nimwesiga E; Barungi G; Takubwa J; Murungi S; Mwebesa D; Kagina G; Mulindwa M; Ahimbisibwe F; Mwesigwa P; Akuma S; Zawedde C; Nyiraguhirwa D; Tumusiime C; Bagaya L; Namara W; Kigozi J; Karungi J; Kankunda R; Enzama R; Latif A; Hakim J; Robertson V; Reid A; Chidziva E; Bulaya-Tembo R; Musoro G; Taziwa F; Chimbetete C; Chakonza L; Mawora A; Muvirimi C; Tinago G; Svovanapasis P; Simango M; Chirema O; Machingura J; Mutsai S; Phiri M; Bafana T; Chirara M; Muchabaiwa L; Muzambi M; Mutowo J; Chivhunga T; Chigwedere E; Pascoe M; Warambwa C; Zengeza E; Mapinge F; Makota S; Jamu A; Ngorima N; Chirairo H; Chitsungo S; Chimanzi J; Maweni C; Warara R; Matongo M; Mudzingwa S; Jangano M; Moyo K; Vere L; Mdege N; Machingura I; Katabira E; Ronald A; Kambungu A; Lutwama F; Mambule I; Nanfuka A; Walusimbi J; Nabankema E; Nalumenya R; Namuli T; Kulume R; Namata I; Nyachwo L; Florence A; Kusiima A; Lubwama E; Nairuba R; Oketta F; Buluma E; Waita R; Ojiambo H; Sadik F; Wanyama J; Nabongo P; Oyugi J; Sematala F; Muganzi A; Twijukye C; Byakwaga H; Ochai R; Muhweezi D; Coutinho A; Etukoit B; Gilks C; Boocock K; Puddephatt C; Grundy C; Bohannon J; Winogron D; Gibb DM; Burke A; Bray D; Babiker A; Walker AS; Wilkes H; Rauchenberger M; Sheehan S; Spencer-Drake C; Taylor K; Spyer M; Ferrier A; Naidoo B; Dunn D; Goodall R; Darbyshire JH; Peto L; Nanfuka R; Mufuka-Kapuya C; Kaleebu P; Pillay D; Robertson V; Yirrell D; Tugume S; Chirara M; Katundu P; Ndembi N; Lyagoba F; Dunn D; Goodall R; McCormick A; Lara AM; Foster S; Amurwon J; Wakholi BN; Kigozi J; Muchabaiwa L; Muzambi M; Weller I; Babiker A; Bahendeka S; Bassett M; Wapakhabulo AC; Darbyshire JH; Gazzard B; Gilks C; Grosskurth H; Hakim J; Latif A; Mapuchere C; Mugurungi O; Mugyenyi P; Burke C; Jones S; Newland C; Pearce G; Rahim S; Rooney J; Smith M; Snowden W; Steens JM; Breckenridge A; McLaren A; Hill C; Matenga J; Pozniak A; Serwadda D; Peto T; Palfreeman A; Borok M; Katabira E
    Lancet; 2010 Jan; 375(9709):123-31. PubMed ID: 20004464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria.
    Gilks CF; Walker AS; Munderi P; Kityo C; Reid A; Katabira E; Goodall RL; Grosskurth H; Mugyenyi P; Hakim J; Gibb DM;
    PLoS One; 2013; 8(2):e57580. PubMed ID: 23437399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
    Walker AS; Ford D; Gilks CF; Munderi P; Ssali F; Reid A; Katabira E; Grosskurth H; Mugyenyi P; Hakim J; Darbyshire JH; Gibb DM; Babiker AG
    Lancet; 2010 Apr; 375(9722):1278-86. PubMed ID: 20347483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART.
    Kiwuwa-Muyingo S; Oja H; Walker A; Ilmonen P; Levin J; Mambule ; Reid A; Mugyenyi P; Todd J;
    BMC Infect Dis; 2013 Aug; 13():395. PubMed ID: 24060199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.
    Medina Lara A; Kigozi J; Amurwon J; Muchabaiwa L; Nyanzi Wakaholi B; Mujica Mota RE; Walker AS; Kasirye R; Ssali F; Reid A; Grosskurth H; Babiker AG; Kityo C; Katabira E; Munderi P; Mugyenyi P; Hakim J; Darbyshire J; Gibb DM; Gilks CF;
    PLoS One; 2012; 7(4):e33672. PubMed ID: 22545079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability.
    Palombi L; Marazzi MC; Guidotti G; Germano P; Buonomo E; Scarcella P; Doro Altan A; Zimba Ida V; San Lio MM; De Luca A;
    Clin Infect Dis; 2009 Jan; 48(1):115-122. PubMed ID: 20380075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/microl.
    DART Trial Team
    AIDS; 2008 Jan; 22(2):237-47. PubMed ID: 18097226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Delayed Switch to Second-Line Antiretroviral Therapy on Mortality, Depending on Definition of Failure Time and CD4 Count at Failure.
    Bell-Gorrod H; Fox MP; Boulle A; Prozesky H; Wood R; Tanser F; Davies MA; Schomaker M
    Am J Epidemiol; 2020 Aug; 189(8):811-819. PubMed ID: 32219384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration.
    Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration
    Lancet HIV; 2019 Feb; 6(2):e105-e115. PubMed ID: 30723008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.
    Kiwuwa-Muyingo S; Kikaire B; Mambule I; Musana H; Musoro G; Gilks CF; Levin JB; Walker AS
    AIDS; 2014 Nov; 28(17):2579-88. PubMed ID: 25574960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa.
    Petersen ML; Tran L; Geng EH; Reynolds SJ; Kambugu A; Wood R; Bangsberg DR; Yiannoutsos CT; Deeks SG; Martin JN
    AIDS; 2014 Sep; 28(14):2097-107. PubMed ID: 24977440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.
    Badje A; Moh R; Gabillard D; Guéhi C; Kabran M; Ntakpé JB; Carrou JL; Kouame GM; Ouattara E; Messou E; Anzian A; Minga A; Gnokoro J; Gouesse P; Emieme A; Toni TD; Rabe C; Sidibé B; Nzunetu G; Dohoun L; Yao A; Kamagate S; Amon S; Kouame AB; Koua A; Kouamé E; Daligou M; Hawerlander D; Ackoundzé S; Koule S; Séri J; Ani A; Dembélé F; Koné F; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatunde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Karcher S; Rouzioux C; Kouame A; Assi R; Bakayoko A; Domoua SK; Deschamps N; Aka K; N'Dri-Yoman T; Salamon R; Journot V; Ahibo H; Ouassa T; Menan H; Inwoley A; Danel C; Eholié SP; Anglaret X;
    Lancet Glob Health; 2017 Nov; 5(11):e1080-e1089. PubMed ID: 29025631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
    Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
    ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
    N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda.
    Masiira B; Baisley K; Mayanja BN; Kazooba P; Maher D; Kaleebu P
    Glob Health Action; 2014; 7():21843. PubMed ID: 24433941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
    Seminari E; De Silvestri A; Boschi A; Tinelli C
    AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
    Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
    Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
    Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.